How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Our top picks have durable insulation and are comfortable to carry Jessie Quinn is ...

At the Strategist, we’ve spent a lot of time searching for adult backpacks (though some of us feel strongly that they are never, ever okay). That has led us to the best travel backpacks, laptop ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...